Advances in Development of New Treatment for Leishmaniasis
about
The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical DiseasesPotential Challenges of Controlling Leishmaniasis in Sri Lanka at a Disease Outbreak.Investigation of Calcium Channel Blockers as Antiprotozoal Agents and Their Interference in the Metabolism of Leishmania (L.) infantum.N-acetyl-cysteine inhibits liver oxidative stress markers in BALB/c mice infected with Leishmania amazonensis.1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.Nuclear DNA replication and repair in parasites of the genus Leishmania: Exploiting differences to develop innovative therapeutic approaches.Nanostructured delivery systems with improved leishmanicidal activity: a critical review.Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.Clinical Efficacy Associated with Enhanced Antioxidant Enzyme Activities of Silver Nanoparticles Biosynthesized Using Moringa oleifera Leaf Extract, Against Cutaneous Leishmaniasis in a Murine Model of Leishmania major.Neolignans isolated from twigs of Ness & Mart (Lauraceae) displayed in vitro antileishmanial activityTransforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in HamstersApplication of Dendrimers for the Treatment of Infectious DiseasesTherapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
P2860
Q26797488-751873F9-058A-4FE7-A71D-9BE46D6FAB36Q33786761-24CA9D1B-81A6-40F3-B4F0-F1535E5B61DBQ36569124-8D46B6C4-6498-43F3-80F0-C473EF293E51Q37626274-B48C734A-981B-47FC-95C2-E5C595571036Q38673741-80FDA92A-63F3-42B9-A342-808ADA0FD533Q38735051-DB42EB5F-DA19-4AB6-9BE5-7E1FAF4D1EADQ39037726-74F2C1C3-88BB-4610-B1C0-6F5E46040004Q40099567-558FD051-A4B1-45DC-87AA-5011EB073E35Q40513787-1AF5E4B6-C2E7-41C9-821D-2911D74D4B4BQ42130947-4EF2FFD9-E436-405D-A41C-888FB54B84CDQ50051086-963FD7F7-8AC1-4800-A4EF-EDF84DDFB786Q54203083-FDFCFB93-1343-4A99-A2EC-2BEDACB80CC8Q57068498-63BB3F2C-F85B-4E7D-86CC-2981A642DABBQ58586136-EDCF02A1-2C21-4709-AE42-516C8013446BQ58696083-006E2CF9-E81D-485C-8063-EA1AE89C4598Q58718800-A1F14D2E-69A7-478B-9E4E-34F8AA094C17
P2860
Advances in Development of New Treatment for Leishmaniasis
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Advances in Development of New Treatment for Leishmaniasis
@ast
Advances in Development of New Treatment for Leishmaniasis
@en
Advances in Development of New Treatment for Leishmaniasis
@nl
type
label
Advances in Development of New Treatment for Leishmaniasis
@ast
Advances in Development of New Treatment for Leishmaniasis
@en
Advances in Development of New Treatment for Leishmaniasis
@nl
prefLabel
Advances in Development of New Treatment for Leishmaniasis
@ast
Advances in Development of New Treatment for Leishmaniasis
@en
Advances in Development of New Treatment for Leishmaniasis
@nl
P2093
P2860
P3181
P356
P1476
Advances in Development of New Treatment for Leishmaniasis
@en
P2093
Antônio Luis de Oliveira Almeida Petersen
Carlos Eduardo Sampaio Guedes
Deborah Bittencourt Mothé Fraga
P2860
P304
P3181
P356
10.1155/2015/815023
P407
P5008
P577
2015-01-01T00:00:00Z
2015-05-11T00:00:00Z